Preclinical safety of recombinant human thrombin.

MLA

Heffernan, Jane K., et al. “Preclinical Safety of Recombinant Human Thrombin.” Regulatory Toxicology and Pharmacology : RTP, vol. 47, no. 1, Feb. 2007, pp. 48–58. EBSCOhost, https://doi.org/10.1016/j.yrtph.2006.07.006.

APA

Heffernan, J. K., Ponce, R. A., Zuckerman, L. A., Volpone, J. P., Visich, J., Giste, E. E., Jenkins, N., Boster, D., Pederson, S., Knitter, G., Palmer, T., Wills, M., Early, R. J., & Rogge, M. C. (2007). Preclinical safety of recombinant human thrombin. Regulatory Toxicology and Pharmacology : RTP, 47(1), 48–58. https://doi.org/10.1016/j.yrtph.2006.07.006

Chicago

Heffernan, Jane K, Rafael A Ponce, Linda A Zuckerman, John P Volpone, Jennifer Visich, Erika E Giste, Nancy Jenkins, et al. 2007. “Preclinical Safety of Recombinant Human Thrombin.” Regulatory Toxicology and Pharmacology : RTP 47 (1): 48–58. doi:10.1016/j.yrtph.2006.07.006.